These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 7064949

  • 1. Urinary and serum steroid concentrations in the management of congenital adrenal hyperplasia. Lack of physiologic correlations.
    Hendricks SA, Lippe BM, Kaplan SA, Lavin N, Mayes DM.
    Am J Dis Child; 1982 Mar; 136(3):229-32. PubMed ID: 7064949
    [Abstract] [Full Text] [Related]

  • 2. Plasma androgens in congenital adrenal hyperplasia: androstenedione concentration as an index of adrenal androgen suppression.
    Keenan BS, McNeel R, Barrett GN, Holcombe JH, Kirkland RT, Clayton GW.
    J Lab Clin Med; 1979 Nov; 94(5):799-808. PubMed ID: 159330
    [No Abstract] [Full Text] [Related]

  • 3. Serum 17-alpha-hydroxyprogesterone, progesterone, estradiol, and testosterone in the diagnosis and management of congenital adrenal hyperplasia.
    Lippe BM, LaFranchi SH, Lavin N, Parlow A, Coyotupa J, Kaplan SA.
    J Pediatr; 1974 Dec; 85(6):782-7. PubMed ID: 4371221
    [No Abstract] [Full Text] [Related]

  • 4. Plasma progesterone, 17-hydroxyprogesterone, androstenedione and testosterone in prepubertal, pubertal and adult subjects with congenital virilizing adrenal hyperplasia as indicators of adrenal suppression.
    Lee PA, Urban MD, Gutai JP, Migeon CJ.
    Horm Res; 1980 Dec; 13(6):347-57. PubMed ID: 7196877
    [Abstract] [Full Text] [Related]

  • 5. Circadian patterns of plasma cortisol, 17-hydroxyprogesterone, and testosterone in congenital adrenal hyperplasia.
    Frisch H, Parth K, Schober E, Swoboda W.
    Arch Dis Child; 1981 Mar; 56(3):208-13. PubMed ID: 7212759
    [Abstract] [Full Text] [Related]

  • 6. The relationships between serum concentrations of 17OH-progesterone and other serum and urinary steroids in patients with congenital adrenal hyperplasia.
    Hughes IA, Winter JS.
    J Clin Endocrinol Metab; 1978 Jan; 46(1):98-104. PubMed ID: 752027
    [Abstract] [Full Text] [Related]

  • 7. Management of congenital adrenal hyperplasia. Urinary steroid estimations--review of their value.
    Bailey CC, Komrower GM, Palmer M.
    Arch Dis Child; 1978 Feb; 53(2):132-5. PubMed ID: 646414
    [Abstract] [Full Text] [Related]

  • 8. [Use of steroid indicators in monitoring the treatment of congenital adrenal hyperplasia].
    Sulcová J, Lisá L, Dvorák P, Hampl R, Stárka L.
    Cesk Pediatr; 1990 Jun; 45(6):353-6. PubMed ID: 2289256
    [Abstract] [Full Text] [Related]

  • 9. Variable efficacy of glucocorticoids in congenital adrenal hyperplasia.
    Hansen JW, Loriaux DL.
    Pediatrics; 1976 Jun; 57(6):942-7. PubMed ID: 934750
    [Abstract] [Full Text] [Related]

  • 10. Growth and skeletal maturation in congenital adrenal hyperplasia. Review of 20 cases.
    Bailey CC, Komrower GM.
    Arch Dis Child; 1974 Jan; 49(1):4-7. PubMed ID: 4361889
    [No Abstract] [Full Text] [Related]

  • 11. Management of congenital adrenal hyperplasia using serum dehydroepiandrosterone sulfate and 17-hydroxyprogesterone concentrations.
    Golden MP, Lippe BM, Kaplan SA, Lavin N, Slavin J.
    Pediatrics; 1978 Jun; 61(6):867-71. PubMed ID: 149950
    [Abstract] [Full Text] [Related]

  • 12. Pregnenolone, 17-OH-pregnenolone, and testosterone in plasma of patients with congenital adrenal hyperplasia.
    McKenna TJ, Jennings AS, Liddle GW, Burr IM.
    J Clin Endocrinol Metab; 1976 May; 42(5):918-25. PubMed ID: 178685
    [Abstract] [Full Text] [Related]

  • 13. Congenital virilizing adrenal hyperplasia without acceleration of growth or bone maturation.
    Aceto T, MacGILLIVRAY MH, Caprano VJ, Munschauer RW, Raiti S.
    JAMA; 1966 Dec 26; 198(13):1341-3. PubMed ID: 6012557
    [No Abstract] [Full Text] [Related]

  • 14. [Virilizing congenital adrenal hyperplasia due to 21-hydroxylase deficiency: early diagnosis and response to 2 treatment schedules].
    Cattani A, Mahaha D, Michaud P, Rodríguez JA, López JM, García H, Foradori A, Velásquez CG.
    Rev Chil Pediatr; 1984 Dec 26; 55(6):374-9. PubMed ID: 6536989
    [No Abstract] [Full Text] [Related]

  • 15. The use of plasma androstenedione in monitoring therapy of patients with congenital adrenal hyperplasia.
    Cavallo A, Corn C, Bryan GT, Meyer WJ.
    J Pediatr; 1979 Jul 26; 95(1):33-7. PubMed ID: 480011
    [Abstract] [Full Text] [Related]

  • 16. The application of a serum 17OH-progesterone radioimmunoassay to the diagnosis and management of congenital adrenal hyperplasia.
    Hughes IA, Winter JS.
    J Pediatr; 1976 May 26; 88(5):766-73. PubMed ID: 1271137
    [Abstract] [Full Text] [Related]

  • 17. Urinary steroids in fifteen cases of congenital virilizing adrenal hyperplasia.
    Mizutani S, Kusunoki T, Matsumoto K, Seki T.
    Endocrinol Jpn; 1967 Jun 26; 14(2):148-57. PubMed ID: 6072545
    [No Abstract] [Full Text] [Related]

  • 18. Gas-liquid chromatography of underivatized steroids: simultaneous determination of urinary 17-ketosteroids, pregnanediol, pregnanetriol, and pregnanetriolone.
    Sanghvi A, Wight C, Serenko A, Balachandran R.
    Clin Chim Acta; 1974 Oct 15; 56(1):49-57. PubMed ID: 4278796
    [No Abstract] [Full Text] [Related]

  • 19. Male pseudohermaphroditism due to multiple defects in steroid-biosynthetic microsomal mixed-function oxidases. A new variant of congenital adrenal hyperplasia.
    Peterson RE, Imperato-McGinley J, Gautier T, Shackleton C.
    N Engl J Med; 1985 Nov 07; 313(19):1182-91. PubMed ID: 2932643
    [Abstract] [Full Text] [Related]

  • 20. [A contribution to the therapy of the congenital adrenal hyperplasia (author's transl)].
    Gleispach H.
    Wien Klin Wochenschr; 1974 Sep 20; 86(17):508-11. PubMed ID: 4408420
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.